Calidi Biotherapeutics, Inc. (CLDI:NYSEMKT) closed at $0.768 on October 21, 2026, down 0.26% on the day. The stock trades 97.2% below its 52-week high of $27.04 and 3.5% above its 52-week low of $0.742. Over the past year, it lost 46.7%. Calidi Biotherapeutics, Inc. is part of the Miscellaneous sector.
In 251 trading sessions since October 21, 2025, CLDI closed higher on 89 days (35%). Its best day was May 21, 2026 (+13.61%) and its worst was March 6, 2026 (-53.12%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 3 times.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Find more stocks like CLDI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.